Radiotherapy Market Size Expected to Reach USD 10.68 Billion by 2031
The global radiotherapy market size is projected to grow from USD 7.98 billion in 2026 to USD 10.68 billion by 2031, registering a CAGR of 6.0% during the forecast period. The market was valued at USD 7.58 billion in 2025. Rising cancer incidence, increasing healthcare investments, and growing demand for precision oncology treatments are key factors fueling market expansion.
The adoption of advanced technologies such as proton beam therapy, adaptive radiotherapy, stereotactic radiosurgery, MRI-guided treatment systems, and artificial intelligence-based treatment planning is transforming cancer care. These innovations are improving tumor-targeting precision while minimizing damage to surrounding healthy tissues, leading to better clinical outcomes and patient experiences.
Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=567
What Is Driving Growth in the Radiotherapy Market?
Technological advancements in radiotherapy are among the strongest drivers of market growth. The increasing adoption of intensity-modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), adaptive radiotherapy, MRI-guided LINAC systems, and AI-powered treatment planning software is significantly improving treatment accuracy and efficiency.
The shift from conventional radiation therapy approaches to image-guided and real-time adaptive treatment systems is helping clinicians deliver highly targeted radiation doses while protecting healthy tissues. As a result, healthcare providers are increasingly integrating advanced radiotherapy solutions into oncology treatment pathways.
Why Is Precision Oncology Increasing Demand for Advanced Radiotherapy?
The growing focus on precision oncology is accelerating demand for advanced radiotherapy technologies capable of delivering personalized cancer treatments. Modern radiotherapy systems use imaging, AI algorithms, and real-time tracking technologies to tailor treatment plans according to individual patient characteristics and tumor behavior.
These innovations are improving treatment effectiveness across multiple cancer types while reducing treatment-related side effects. The increasing emphasis on personalized medicine is expected to further strengthen radiotherapy adoption over the coming years.
How Is Artificial Intelligence Transforming Radiotherapy?
Artificial intelligence is becoming an increasingly important component of modern radiotherapy workflows. AI-powered treatment planning systems help optimize radiation dosing, automate contouring processes, and improve treatment accuracy through advanced data analysis and predictive modeling.
In addition, AI-enabled adaptive radiotherapy systems can make real-time treatment adjustments based on anatomical changes observed during therapy. These capabilities are enhancing workflow efficiency, reducing planning times, and improving overall treatment outcomes.
What Challenges Continue to Impact Market Expansion?
Despite strong growth opportunities, access to advanced radiotherapy technologies remains limited in many low- and middle-income countries. High equipment costs, infrastructure requirements, and shortages of trained oncology professionals continue to restrict adoption in underserved regions.
Manufacturers also face challenges related to regulatory complexity and lengthy approval timelines. Advanced technologies such as proton therapy systems, MRI-guided radiotherapy platforms, and AI-driven software require extensive clinical validation and compliance with evolving regulatory requirements before commercialization.
Why Are Emerging Markets Creating Significant Opportunities?
Emerging economies such as China, India, Brazil, and Mexico are presenting substantial growth opportunities for radiotherapy providers. Increasing healthcare expenditure, expanding oncology infrastructure, and growing government investment in cancer treatment services are accelerating market development across these regions.
The growing adoption of advanced technologies such as proton therapy, CyberKnife radiosurgery, and AI-enabled treatment planning is further enhancing access to precision cancer care. In addition, rising medical tourism and lower treatment costs are supporting demand for advanced radiotherapy services in emerging markets.
Request Sample Pages – https://www.marketsandmarkets.com/requestsampleNew.asp?id=567
Which Segment Leads the Radiotherapy Market?
By offering, the systems segment is expected to witness significant growth due to increasing adoption of advanced radiotherapy equipment and growing demand for technology-enabled cancer treatment solutions. This segment includes external beam radiotherapy systems, brachytherapy equipment, consumables, probes, and applicators.
By technology, external beam radiotherapy accounted for the largest market share and is expected to maintain its dominance during the forecast period. Its ability to deliver highly precise radiation treatment while minimizing exposure to healthy tissues continues to support widespread clinical adoption.
Why Does External Beam Radiotherapy Dominate the Market?
External beam radiotherapy (EBRT) dominates both the application and procedure segments due to its non-invasive nature, treatment precision, and broad applicability across multiple cancer types. Advances in image-guided radiation therapy, stereotactic techniques, and adaptive treatment approaches are further strengthening its market position.
The increasing use of EBRT for newly diagnosed cancers, combined with growing demand for personalized treatment approaches, is expected to support continued segment growth throughout the forecast period.
Why Do Hospitals Account for the Largest Market Share?
Hospitals represent the largest end-user segment due to their ability to provide comprehensive cancer treatment services and access to advanced radiotherapy technologies. Large patient volumes, availability of skilled oncology professionals, and increasing investments in healthcare infrastructure continue to drive adoption within hospital settings.
The growing number of cancer treatment centers and hospital-based oncology programs in developing regions is also contributing to increased demand for radiotherapy systems and associated services.
Why Is Asia Pacific the Fastest-Growing Region?
Asia Pacific is expected to register the highest growth rate during the forecast period due to rising cancer prevalence, aging populations, expanding healthcare infrastructure, and increasing government support for oncology care. Countries such as China, India, Japan, South Korea, and Australia are investing heavily in advanced cancer treatment technologies.
Growing adoption of linear accelerators, image-guided radiotherapy systems, and proton therapy technologies, along with increasing medical tourism and healthcare spending, are expected to further accelerate regional market growth.
Who Are the Leading Companies in the Radiotherapy Market?
Key companies operating in the market include Siemens Healthineers AG, Elekta, Accuray Incorporated, IBA Worldwide, ViewRay, Inc., Hitachi Ltd., Carl Zeiss Meditec AG, MIM Software Inc., Panacea Medical Technologies Pvt. Ltd., and Koninklijke Philips N.V..
These companies are investing in precision oncology technologies, proton therapy platforms, AI-driven treatment planning systems, and adaptive radiotherapy solutions. Strategic collaborations, product innovation, and expansion into emerging markets continue to strengthen their competitive positions.
Inquire Before Buying – https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=567
Why Does the Radiotherapy Market Matter Now?
Cancer remains one of the leading causes of mortality worldwide, increasing the demand for effective, precise, and accessible treatment options. Radiotherapy continues to play a critical role in cancer management by offering targeted treatment solutions that improve survival rates and quality of life.
As innovations in artificial intelligence, adaptive treatment planning, image-guided therapy, and proton beam technology continue to advance, radiotherapy is expected to become even more integral to precision oncology. The market presents substantial opportunities for healthcare providers, technology developers, medical device manufacturers, and investors focused on the future of cancer care.
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/radiotherapy-monitoring-devices-market-567.html
